SCHEMBL6637581

SCHEMBL6637581

Cc1coc2cc(N3C(=O)c4ccccc4C3=O)ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
KCNA3 P22001 3/20 0.46
GRM1 Q13255 5/20 0.45
GRM4 Q14833 1/20 0.45
ALDH1A1 P00352 2/20 0.45
HSD17B10 Q99714 2/20 0.45
KDM4E B2RXH2 1/20 0.45
USP2 O75604 1/20 0.45
HPGD P15428 1/20 0.45
PTGER4 P35408 1/20 0.44
NPC1 O15118 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP1 P29466 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PIM3 Q86V86 1/20 0.41
HIPK4 Q8NE63 1/20 0.41
SCN2A Q99250 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11455236 0.81 PIN1 (0.50) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL2732660 0.78 MAOB (0.53) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL11866904 0.74 MEN1 (1.00) MEN1KMT2AGRM1GRM4ALDH1A1
SCHEMBL19685948 0.73 ALDH1A1 (0.43) MEN1KMT2AKCNA3ALDH1A1HSD17B10
SCHEMBL11473653 0.72 NPC1 (0.48) MEN1KMT2AALDH1A1HSD17B10KDM4E
SCHEMBL19686011 0.72 ALDH1A1 (0.42) MEN1KMT2AKCNA3ALDH1A1HSD17B10
SCHEMBL19685946 0.72 ALDH1A1 (0.42) MEN1KMT2AKCNA3ALDH1A1HSD17B10
SCHEMBL19686012 0.72 ALDH1A1 (0.42) MEN1KMT2AKCNA3ALDH1A1HSD17B10
SCHEMBL12173010 0.70 MEN1 (0.72) MEN1KMT2AGRM1ALDH1A1HPGD
SCHEMBL11864269 0.70 MEN1 (0.72) MEN1KMT2AALDH1A1HSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
EP-1100795-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM ZENTRALE GMBH (DE) 2001-05-23 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed
WO-2000008014-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-02-17 WO disclosed